Pierre Vogel

13.8k total citations
529 papers, 11.0k citations indexed

About

Pierre Vogel is a scholar working on Organic Chemistry, Molecular Biology and Spectroscopy. According to data from OpenAlex, Pierre Vogel has authored 529 papers receiving a total of 11.0k indexed citations (citations by other indexed papers that have themselves been cited), including 454 papers in Organic Chemistry, 167 papers in Molecular Biology and 67 papers in Spectroscopy. Recurrent topics in Pierre Vogel's work include Carbohydrate Chemistry and Synthesis (173 papers), Asymmetric Synthesis and Catalysis (100 papers) and Synthetic Organic Chemistry Methods (95 papers). Pierre Vogel is often cited by papers focused on Carbohydrate Chemistry and Synthesis (173 papers), Asymmetric Synthesis and Catalysis (100 papers) and Synthetic Organic Chemistry Methods (95 papers). Pierre Vogel collaborates with scholars based in Switzerland, France and Spain. Pierre Vogel's co-authors include Srinivas Reddy Dubbaka, Chandra M. R. Volla, Pierre‐Alain Carrupt, Inmaculada Robina, Sandrine Gerber‐Lemaire, Claude Le Drian, Eric Vieira, Ana T. Carmona, Antonio J. Moreno‐Vargas and A. Alan Pinkerton and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Pierre Vogel

513 papers receiving 10.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Vogel Switzerland 48 9.4k 3.5k 963 786 698 529 11.0k
Stephen F. Martin United States 59 11.3k 1.2× 4.8k 1.4× 1.1k 1.1× 339 0.4× 1.3k 1.9× 381 14.0k
Hans‐Joachim Knölker Germany 56 10.5k 1.1× 2.9k 0.8× 2.0k 2.1× 357 0.5× 743 1.1× 301 14.1k
J. Carlos Menéndez Spain 44 7.3k 0.8× 2.1k 0.6× 952 1.0× 306 0.4× 823 1.2× 294 9.2k
Ken Hirotsu Japan 41 2.8k 0.3× 1.8k 0.5× 1.6k 1.6× 552 0.7× 197 0.3× 211 5.6k
Henry Rapoport United States 60 7.5k 0.8× 6.0k 1.7× 675 0.7× 929 1.2× 1.3k 1.9× 401 12.8k
Jieping Zhu Switzerland 83 22.7k 2.4× 5.4k 1.5× 2.5k 2.6× 970 1.2× 1.6k 2.3× 534 24.8k
Fahmi Himo Sweden 54 5.6k 0.6× 4.7k 1.3× 2.7k 2.8× 420 0.5× 232 0.3× 206 11.2k
Osamu Yonemitsu Japan 35 5.1k 0.5× 1.8k 0.5× 326 0.3× 396 0.5× 804 1.2× 286 6.1k
Carsten Strohmann Germany 48 6.4k 0.7× 1.7k 0.5× 2.9k 3.1× 266 0.3× 684 1.0× 412 9.0k

Countries citing papers authored by Pierre Vogel

Since Specialization
Citations

This map shows the geographic impact of Pierre Vogel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Vogel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Vogel more than expected).

Fields of papers citing papers by Pierre Vogel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Vogel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Vogel. The network helps show where Pierre Vogel may publish in the future.

Co-authorship network of co-authors of Pierre Vogel

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Vogel. A scholar is included among the top collaborators of Pierre Vogel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Vogel. Pierre Vogel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsumoto, Saki, Jian‐Fei Bai, Somi Reddy Majjigapu, et al.. (2023). Anticancer Activities of Novel Nicotinamide Phosphoribosyltransferase Inhibitors in Hematological Malignancies. Molecules. 28(4). 1897–1897. 4 indexed citations
2.
Vogel, Pierre, et al.. (2016). Disaccharide mimics as drugs against cancer and epitopes for anti-cancer vaccine candidates. 1 indexed citations
3.
Moreno‐Clavijo, Elena, Ana T. Carmona, Antonio J. Moreno‐Vargas, et al.. (2009). Synthesis of novel pyrrolidine 3,4-diol derivatives as inhibitors of α-L-fucosidases. Organic & Biomolecular Chemistry. 7(6). 1192–1192. 38 indexed citations
4.
Robina, Inmaculada & Pierre Vogel. (2007). Synthesis of monosaccharides and analogues - Part three: Monosaccharides from simple achiral unsaturated compounds. Infoscience (Ecole Polytechnique Fédérale de Lausanne). 25(6). 1 indexed citations
5.
Bouchez, Laure C. & Pierre Vogel. (2005). Synthesis of the C(1)–C(11) Polyene Fragment of Apoptolidin with a New Sulfur Dioxide‐Based Organic Chemistry. Chemistry - A European Journal. 11(16). 4609–4620. 16 indexed citations
6.
Vogel, Pierre, et al.. (2004). C-linked disaccharides analogues of the T epitope: Toward an artificial anti-cancer vaccine. Infoscience (Ecole Polytechnique Fédérale de Lausanne). 228. 1 indexed citations
7.
Turks, Māris, Xiaogen Huang, & Pierre Vogel. (2004). Expeditious Asymmetric Synthesis of a Stereoheptad Corresponding to the C(19)–C(27)‐Ansa Chain of Rifamycins: Formal Total Synthesis of Rifamycin S. Chemistry - A European Journal. 11(2). 465–476. 21 indexed citations
8.
Vogel, Pierre, et al.. (2002). Substituent Effect on the Competition between Hetero-Diels-Alder and Cheletropic Additions of Sulfur Dioxide to 1-Substituted Buta-1,3-dienes. Helvetica Chimica Acta. 85(3). 733–733. 22 indexed citations
10.
Audin, Michèle, John W. Morgan, Pierre Vogel, & Daniel Bennequin. (2001). Nouveaux invariants en géométrie et en topologie. 2 indexed citations
11.
Vogel, Pierre, et al.. (2001). Stereoselective synthesis of new 8-oxabicyclo[3.2.1]oct-6-en-2-one and 8-oxabicyclo[3.2.1] octa-3,6-dien-2-one derivatives. The electron-releasing and electron-withdrawing effects of homoconjugated ketones†. Infoscience (Ecole Polytechnique Fédérale de Lausanne). 40(10). 898–904.
12.
Popowycz, Florence, et al.. (2001). Derivatives of (2R,3R,4S)-2-Aminomethylpyrrolidine-3,4-diol are selective α-Mannosidase inhibitors. Bioorganic & Medicinal Chemistry Letters. 11(18). 2489–2493. 49 indexed citations
13.
Vogel, Pierre, et al.. (2000). A New, Non-Iterative Asymmetric Synthesis of Long-Chain 1,3-Polyols. Chemistry - A European Journal. 6(22). 4091–4103. 31 indexed citations
14.
Vogel, Pierre. (1998). Combinatorial Diels-Alder approach to the synthesis of anti-tumor anthracyclines and analogues. Current Organic Chemistry. 2(3). 255–280. 6 indexed citations
15.
Vogel, Pierre. (1998). Combinatorial Diels-Aider Approach to the Synthesis of Anti-tumor Anthracyclines and Analogues. Current Organic Chemistry. 2(3). 255–280. 7 indexed citations
16.
Vogel, Pierre, et al.. (1994). Remote Substituent Effects on the Cheletropic and Homocheletropic Additions of Sulfur-Dioxide to Exocyclic Polyenes Grafted onto Bicyclo[2.2.2]Octane Skeletons. Infoscience (Ecole Polytechnique Fédérale de Lausanne). 131(8). 822–827.
17.
Carrupt, Pierre‐Alain, et al.. (1988). Synthesis and Circular-Dichroism of 5-Halogenobicyclo[2.2.1]Hept-5-En-2-Ones and 6-Halogenobicyclo[2.2.1]Hept-5-En-2-Ones - Tests for the Dekkers Quantitative Chirality Rule. Infoscience (Ecole Polytechnique Fédérale de Lausanne).
19.
Vogel, Pierre. (1982). Exocyclic Dienes and the Synthesis of Anthracyclins. CHIMIA International Journal for Chemistry. 36(1). 10–11. 1 indexed citations
20.
Vogel, Pierre, et al.. (1975). Double Addition of Fluorosulfuric Acid to Norbornadiene and Quadricyclane. CHIMIA International Journal for Chemistry. 29(7). 306–306. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026